Analysis of molecular breakpoint and m-RNA transcripts in a prospective randomized trial of interferon in chronic myeloid leukaemia: no correlation with clinical features, cytogenetic response, duration of chronic phase, or survival.

Shepherd, P

Analysis of molecular breakpoint and m-RNA transcripts in a prospective randomized trial of interferon in chronic myeloid leukaemia: no correlation with clinical features, cytogenetic response, duration of chronic phase, or survival. [electronic resource] - British journal of haematology Mar 1995 - 546-54 p. digital

Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0007-1048

10.1111/j.1365-2141.1995.tb08362.x doi


Adolescent
Adult
Aged
Base Sequence
Female
Fusion Proteins, bcr-abl--genetics
Humans
Interferon-alpha--therapeutic use
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--genetics
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative--genetics
Male
Middle Aged
Molecular Sequence Data
Oncogene Proteins--genetics
Prognosis
Prospective Studies
Protein-Tyrosine Kinases
Proto-Oncogene Proteins
Proto-Oncogene Proteins c-bcr
RNA Splicing
RNA, Messenger--genetics
RNA, Neoplasm--genetics
Survival Rate
Time Factors
Transcription, Genetic--genetics